Teleconsultation experience with the idiopathic inflammatory myopathies: a prospective observational cohort study during the COVID-19 pandemic

• Published in: Rheumatology international Vol. 41; no. 1; pp. 67 - 76
• Main Authors: Naveen, R., Sundaram, T. G., Agarwal, Vikas, Gupta, Latika
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.01.2021; Springer Nature B.V
• Subjects: Adult; Case-Control Studies; Child; Cohort analysis; Coronaviruses; COVID-19; Disease Progression; Female; Humans; India; Inflammatory diseases; Male; Medicine; Medicine & Public Health; Middle Aged; Musculoskeletal diseases; Myositis - classification; Myositis - therapy; Observational Research; Observational studies; Pandemics; Prospective Studies; Rheumatology; SARS-CoV-2; Telemedicine; Telemedicine - methods; Telemedicine - statistics & numerical data; Text Messaging; India; Teleconsultation; COVID-19; Myositis; Triage; Remote consultation
• ISSN: 0172-8172; 1437-160X
• DOI: 10.1007/s00296-020-04737-8

Teleconsultation has assumed a central role in the management of chronic and disabling rheumatic diseases, such as the idiopathic inflammatory myopathies (IIM), during COVID-19. However, the feasibility, challenges encountered, and outcomes remain largely unexplored. Here, we describe our teleconsultation experience in a prospectively followed cohort of adult and juvenile IIM. 250 IIM enrolled into the MyoCite cohort (2017-ongoing) were offered the option of audio/visual teleconsultation using WhatsApp during the nationwide lockdown. Clinical outcomes (major/minor relapse) and prescription changes were compared between IIM subsets. Socio-demographic and clinico-serological characteristics of those who sought teleconsultation were compared with those who did not. 151 teleconsultations were sought over a 93 day period by 71 (52.2%) of 136 IIM (median age 38 years, F:M 4.5:1). Nearly one-third (38%) consulted on an emergency basis, with voice consultations being the primary medium of communication. Over a quarter (26.8%) reported relapse (15.5% minor, 11.3% major), these being more common in JDM [71.4%, OR 8.9 (1.5–51)] as compared with adult IIM, but similar across various antibody-based IIM subtypes. Patients who relapsed required more consultations [2(2–3) vs 1(1–2), p 0.009]. The demographic and socioeconomic profile of the patients seeking consultation ( n  = 71) was not different from those who did not ( n  = 65). Voice-based teleconsultations may be useful to diagnose and manage relapses in IIM during the pandemic. Patient education for meticulous and timely reporting may be improve care, and larger multicentre studies may identify subsets of IIM that require greater care and early tele-triage for effective management of the condition.